PRUCALOPRIDE
- Product NDC
- 46708-077
- Requested package NDC
- 46708-077-30
- 11-digit product format
- 467080077
- Labeler code
- 46708
- Product ID
- 46708-077_89a7bdb1-e1cd-4986-bab9-a939dc764faa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PRUCALOPRIDE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Alembic Pharmaceuticals Limited
- Application
- ANDA219234
- Marketing category
- ANDA
- Marketing start
- 2026-07-31
- Substance
- PRUCALOPRIDE SUCCINATE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Serotonin 4 Receptor Agonists [MoA], Serotonin-4 Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219234-001 | PRUCALOPRIDE SUCCINATE | PRUCALOPRIDE SUCCINATE | EQ 1MG BASE | TABLET / ORAL | AB | 2026-07-27 | |
| A219234-002 | PRUCALOPRIDE SUCCINATE | PRUCALOPRIDE SUCCINATE | EQ 2MG BASE | TABLET / ORAL | AB | 2026-07-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219234-001 | AB |
| A219234-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219234-001 | PRUCALOPRIDE SUCCINATE | EQ 1MG BASE | TABLET / ORAL | AB | 2026-07-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A219234-002 | PRUCALOPRIDE SUCCINATE | EQ 2MG BASE | TABLET / ORAL | AB | 2026-07-27 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219234-001 | PRUCALOPRIDE SUCCINATE | EQ 1MG BASE | TABLET / ORAL | AB | 2026-07-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A219234-002 | PRUCALOPRIDE SUCCINATE | EQ 2MG BASE | TABLET / ORAL | AB | 2026-07-27 | caaa826d4ba7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219234-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A219234-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219234-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A219234-002 | AB | 1 | caaa826d4ba7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PRUCALOPRIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PRUCALOPRIDE SUCCINATE | 1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4V2G75E1CK | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 89a7bdb1-e1cd-4986-bab9-a939dc764faa | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PRUCALOPRIDE | PRUCALOPRIDE | Alembic Pharmaceuticals Limited | 89a7bdb1-e1cd-4986-bab9-a939dc764faa | 2026-07-31 | Warnings, Adverse reactions | 219234 ANDA219234 46708-077-30 46708-077 46708007730 |
| PRUCALOPRIDE | PRUCALOPRIDE | Alembic Pharmaceuticals Inc. | a537fb70-eb4e-4498-aaef-9944ff390009 | 2026-07-31 | Warnings, Adverse reactions | 219234 ANDA219234 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 46708-077-30 | 46708007730 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-077-30) | 2026-07-31 | No | No | Current |